Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loo

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the catJ A Straw, T L Loo, C C de Vera, et al.
Cell|December 7, 2000
Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complexK Brubaker, S M Cowley, K Huang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolateS W Hall, T F Tenczynski, R S Benjamin, et al.
Journal of Neuro-Oncology|January 1, 1983
Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986)N Savaraj, K Lu, L G Feun, et al.
Cancer Research|June 1, 1982
Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumorsD J Stewart, M Leavens, M Maor, et al.
Journal of Clinical Pharmacology|May 1, 1978
Clinica, pharmacology of tetrahydrouridineD H Ho, G P Bodey, S W Hall, et al.
Cancer Investigation|January 1, 1983
Tumor penetration of AMSA in manZ G Guo, N Savaraj, L G Feun, et al.
Journal of Neuro-Oncology|January 1, 1983
The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beaglesL G Feun, N Savaraj, K Lu, et al.
American Journal of Clinical Oncology|August 1, 1985
Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II studyD F Chiuten, A Miller, M Valdivieso, et al.
Nanoscale|May 1, 2015
Metal nanocluster light-emitting devices with suppressed parasitic emission and improved efficiency: exploring the impact of photophysical propertiesT-W Koh, A M Hiszpanski, M Sezen, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the catJ A Straw, T L Loo, C C de Vera, et al.
Cell|December 7, 2000
Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complexK Brubaker, S M Cowley, K Huang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolateS W Hall, T F Tenczynski, R S Benjamin, et al.
Journal of Neuro-Oncology|January 1, 1983
Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986)N Savaraj, K Lu, L G Feun, et al.
Cancer Research|June 1, 1982
Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumorsD J Stewart, M Leavens, M Maor, et al.
Journal of Clinical Pharmacology|May 1, 1978
Clinica, pharmacology of tetrahydrouridineD H Ho, G P Bodey, S W Hall, et al.
Cancer Investigation|January 1, 1983
Tumor penetration of AMSA in manZ G Guo, N Savaraj, L G Feun, et al.
Journal of Neuro-Oncology|January 1, 1983
The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beaglesL G Feun, N Savaraj, K Lu, et al.
American Journal of Clinical Oncology|August 1, 1985
Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II studyD F Chiuten, A Miller, M Valdivieso, et al.
Nanoscale|May 1, 2015
Metal nanocluster light-emitting devices with suppressed parasitic emission and improved efficiency: exploring the impact of photophysical propertiesT-W Koh, A M Hiszpanski, M Sezen, et al.
Pageof 19